Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status

The large randomized placebo controlled trials of the Women’s Health Initiative have shown that the combination of estrogen and progestin medroxyprogesterone acetate (MPA) protects from colorectal cancer in postmenopausal women. No effect was observed in women treated with estrogen alone. This sugge...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Meijer, Bartolomeus J., Wielenga, Mattheus C.B., Hoyer, Patricia B., Amos-Landgraf, James M., Hakvoort, Theodorus B.M., Muncan, Vanesa, Heijmans, Jarom, van den Brink, Gijs R.
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078141/
https://ncbi.nlm.nih.gov/pubmed/30093969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25703
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares